# Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

Study · id `cardio:ct-nct02151929` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02151929](<https://clinicaltrials.gov/study/NCT02151929>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02151929

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02151929. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2013-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02151929, source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT02151929, source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)
- Primary completion: 2013-08 (actual) (ClinicalTrials.gov record NCT02151929, source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)
- Completion: 2014-04 (actual) (ClinicalTrials.gov record NCT02151929, source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT02151929, source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02151929-2014-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction
- Condition: ST Elevation Acute Myocardial Infarction
- Intervention (Device): Bioresorbable vascular scaffold
- Intervention (Device): Everolimus eluting stent
- Lead sponsor: San Giuseppe Moscati Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: fec420e4304a0a7c66b91a9ff2af167e97b596b8fe5a852eb85f9a87ba246266
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
